Andrew Huberman· PhD
drugs that are designed to increase certain monoamines in order to treat depression only work in about 40% of depressed people that take them and they have a lot of side effects
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
drugs that are designed to increase certain monoamines in order to treat depression only work in about 40% of depressed people that take them and they have a lot of side effects
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the monoamine hypothesis of depression which drove the discovery and development of all the drugs like ssris w Butrin etc those drugs often can provide support for people with depression again only 40% of people get true relief from their depression and again there are some side effect issues or major side effect issues in some cases that have to be dealt with but even the positive effects even under the best conditions oftentimes those effects don't kick in for weeks or months after somebody initiates taking the drug
if somebody has severe depression and they take any number of the available pharmaceutical agents that are out there, SSRIs, serotoninergic agents increased, dopamine increased, whatever that sometimes they experience relief, but they're often serious side effects. Sometimes they don't experience relief.